EMA recommends suspending licences for 700 drugs over flawed analyses by GVK BiosciencesThe European Medicines Agency is recommending that the marketing authorisation be suspended for more than 700 generic products tested by GVK Biosciences.…
Latest advances in hepatitis C therapy The availability of new protease inhibitors is revolutionising the treatment of hepatitis C virus infection.…
Use of NSAIDs associated with surgery complication Use of non-steroidal anti-inflammatory drugs (NSAIDs) in patients undergoing surgery may be associated with anastomotic leak at the surgical junction, research confirms.…
Human Protein Atlas reveals drug targets The Human Protein Atlas shows the locations of almost 17,000 different proteins in the human body and could offer invaluable guidance for drug developers. …
EU approval of AbbVie’s hepatitis C combination therapies challenges Gilead’s Harvoni A highly effective therapy for patients with hepatitis C is being launched by AbbVie in the EU over the next couple of months in direct competition with another treatment made by Gilead that was approved in 2014 and is now being rolled out. …
US President launches ‘precision medicine’ initiative Precision medicine got a shot in the arm on 20 January 2015, when US President Barack Obama launched a Precision Medicine Initiative to help cure diseases like cancer and diabetes.…
Study sheds light on factors affecting adherence in patients with diabetes Patients with type 2 diabetes are more likely to take their medicines as prescribed if they are male, have a degree and earn more than US$60,000 a year.…
Almost 42% of US drinkers report taking drugs that interact with alcohol Some 41.5% of US adults who drink alcohol report taking medicines known to interact with alcohol, according to research published in Alcoholism: Clinical and Experimental Research.…
Searching social networks to detect adverse reactions Regulators and pharmaceutical companies are monitoring social media posts for potential adverse drug reaction signals.…
Women taking valproate should be told about risks of developmental disorders in offspringWomen taking valproate should be told about the risks of developmental disorders in children exposed to the drug during pregnancy, says the UK medicines regulator.…
